Interim recommendations for use of recombinant COVID-19 vaccine updated to reflect latest evidence

By | July 30, 2021
The interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) have been updated to reflect latest evidence.